Chuan Shih

This inventor holds 41 USPTO granted patents, plus 3 CIPO patents and 3 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Eli Lilly and Company, Princeton University, National Health Research Institutes. Active years: 1989-2026.

USPTO Granted Patents = 41

% Patents Active = 73.2

CIPO Patents = 3 (Patent Applications = 5)

EPO Patents = 3 (Patent Applications = 8)

Average Co-Inventor Count = 3.8

ph-index = 13

Forward Citations = 351(Granted Patents)

Location History:

Indianapolis, IN (US) (1989 - 2012)
Carmel, IN (US) (1993 - 2024)

Company Filing History:

22 out of 4,507

Eli Lilly and Company

National Health Research Institutes

Regents of the University of Minnesota

patents

6. 1 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1989-2026

Loading Chart...

Areas of Expertise:

Pharmaceutical Uses

Kinase Inhibitors

Anti-Abeta Antibodies

Heterocyclic Compounds

Anti-Cancer Agents

Alzheimer's Disease

Protein Kinase Inhibitors

Thiazolidinone Compounds

Tetrahydroisoquinolines

Pyridopyrimidines

Antineoplastic Agents

Fungal Infections

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12710427 - ANTI-HUMAN NEUROTENSIN RECEPTOR 1 ANTIBODY AND USE THEREOF (2026-08-18),

2. 12679827 - Pyrimidine compounds and their pharmaceutical uses (2026-07-14),

3. 12668584 - Heterocyclic compounds as kinase inhibitors for therapeutic uses (2026-06-30),

4. 11878986 - Poly heterocyclic conjugates and their pharmaceutical uses (2024-01-23),

5. 11623951 - Antibodies to R-spondin 3 (2023-04-11),

6. 11084873 - Anti-Abeta antibodies and uses thereof (2021-08-10),

7. 10882854 - Heterocyclic compounds and use thereof (2021-01-05),

8. 10597378 - Tetrahydroisoquinolines for use as MOR/NOP dual agonists (2020-03-24),

9. 10584120 - Benzimidazole compounds and use thereof for treating Alzheimer's Disease or Huntington's Disease (2020-03-10),

10. 10544113 - Thiazolidinone compounds and use thereof (2020-01-28),

11. 10300061 - Aminothiazole compounds as protein kinase inhibitors (2019-05-28),

12. RE43878 - Amidophenoxyindazoles useful as inhibitors of c-Met (2012-12-24),

13. 8030302 - Amidophenoxyindazoles useful as inhibitors of c-Met (2011-10-04),

14. 7767674 - Kinase inhibitors (2010-08-03),

15. 7652015 - Kinase inhibitors (2010-01-26),

Title: The Innovative Journey of Chuan Shih

Introduction: Chuan Shih, a distinguished inventor based in Carmel, IN (US), has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Chuan Shih holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, with his most recent patent focusing on a cutting-edge sustainable energy solution.

Career Highlights: With a career spanning over two decades, Chuan Shih has worked for leading tech companies, where he spearheaded research and development projects that led to the creation of revolutionary products.

Collaborations: Throughout his career, Chuan Shih has collaborated with top researchers, engineers, and scientists from renowned universities and research institutions, fostering a culture of innovation and excellence.

Conclusion: Chuan Shih's dedication to innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and shape the future of various industries.